Europe Probiotic Supplements Market Overview:

Market Size in 2024: USD 2.1 Billion
Market Forecast in 2033: USD 3.1 Billion
Market Growth Rate 2025-2033: 4.5%

The Europe probiotic supplements market size reached USD 2.1 billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.1 billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033.

Europe Probiotic Supplements Industry Trends & Growth Drivers:

EMA PRIME Fast-Track Opens Floodgates for Strain-Specific Health Claims

The European Medicines Agency’s draft guidance (March 2025) introduces tiered “qualified health claims” for probiotics. By August 2025, the agency had accepted 27 full genomic dossiers-double 2024 levels. Chr. Hansen filed Lactobacillus rhamnosus GG for respiratory-tract health in June 2025, leveraging its €70 m 2024 clinical-trial dataset. The company expects first approvals by Q2 2026, setting a precedent for strain-specific marketing across the EU.

Silver-Economy Demand Boosts Pharmacist-Channel Sales by 22%

Eurostat projects Europe’s 60-plus population will reach 150 million by 2030. IMS Health pharmacy audits show probiotic supplement sales to seniors grew 22% in 2024, with pharmacists influencing 61% of purchases. Bayer launched “Phillips’ Probiotic 50+” across Germany, Italy, and Spain in January 2025; early sell-through data from IMS indicate 18 % month-on-month growth. Boots UK expanded shelf space for senior-focused SKUs by 40% in August 2025, citing repeat-purchase loyalty.

Precision-Microbiome Start-Ups Land €310 m in 2025 VC Deals

PitchBook logged a record €310 m in European microbiome investments in 2024. In May 2025, Ferring Pharmaceuticals invested €45 m in Series-C funding for MyBiotics, an Israeli-Dutch start-up offering AI-driven stool-microbiome analysis and personalised probiotic blends. The partnership will launch direct-to-consumer test kits in the Netherlands and Belgium in Q4 2025, with EU-wide rollout slated for 2026 pending GDPR compliance. Separately, Danish firm SNIPR Technologies raised €35 m in July 2025 for CRISPR-engineered probiotics targeting antibiotic-resistant gut infections, underscoring the shift toward precision therapeutics.

Download a sample copy of the report: https://www.imarcgroup.com/europe-probiotic-supplements-market/requestsample

Europe Probiotic Supplements Market Segmentation:

Breakup by Ingredient:

• Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
• Yeast
  • Saccharomyces Boulardii
  • Others

Breakup by Form:

• Powder
• Tablet
• Liquid
• Others

Breakup by Application:

• Food Supplements
• Nutritional Supplements
• Speciality Nutrients
• Infant Formula
• Others

Breakup by Distribution Channel:

• Supermarkets and Hypermarkets
• Hospitals & Clinics
• Pharmacies
• Online
• Others

Breakup by Country:

• Germany
• France
• United Kingdom
• Russia
• Italy
• Spain
• Others

Competitive Landscape:

BioGaia, Bio-K Plus International Inc., Chr. Hansen Holding A/S, Daflorn Probiotics UK, Danone S.A, Exden, IPA EUROPE, PepsiCo Inc., Vitafoods and Yakult Honsha

Europe Probiotic Supplements Market News:

• 12 Aug 2025 - Probi signs a €25 m deal to supply custom probiotic blends to Nestlé Health Science across 20 EU markets.
• 10 Aug 2025 - The UK’s MHRA grants conditional approval for the first probiotic aimed at reducing antibiotic-associated diarrhoea in hospitals.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.